Theracryf Plc (AIM:TCF)
London
· Delayed Price · Currency is GBP · Price in GBX 0.2550
-0.0240 (-9.41%)
Jul 8, 2025, 4:35 PM GMT+1
Theracryf Market Cap
Theracryf has a market cap or net worth of 5.43 million as of July 8, 2025. Its market cap has increased by 49.50% in one year.
Market Cap
5.43M
Enterprise Value
1.32M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.26
Market Cap Chart
Since October 21, 2015, Theracryf's market cap has decreased from 25.60M to 5.43M, a decrease of -78.78%. That is a compound annual growth rate of -14.74%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 158.45B |
| GSK plc | 56.46B |
| Haleon | 33.36B |
| Smith & Nephew | 9.70B |
| ConvaTec Group | 5.40B |
| Hikma Pharmaceuticals | 4.37B |
| HUTCHMED (China) | 1.93B |
| Indivior | 1.40B |